Epstein-Barr Virus quantitation by real-time PCR targeting multiple gene segments: A novel approach to screen for the virus in paraffin-embedded tissue and plasma

Journal of Molecular Diagnostics

Volumn 6, Issue 4, 2004, Pages 378-385

  Ryan, Julie L ^a   Fan, Hongxin ^a   Glaser, Sally L ^b   Schichman, Steven A ^c   Raab Traub, Nancy ^d   Gulley, Margaret L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NORTHERN CALIFORNIA CANCER CENTER   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PARAFFIN; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE DELETION; GENETIC CONSERVATION; GENETIC POLYMORPHISM; GENOMIC IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; VALIDATION PROCESS; VIRUS GENOME; VIRUS LOAD;

HUMAN HERPESVIRUS 4;

EID: 8744233976     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60535-1     Document Type: Article

References (16)

1. Gulley ML: Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn 2001, 3:1-10
2. Thorley-Lawson DA: Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 2001, 1:75-82
3. Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, De Matteo E, Gould VE: Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res 2002, 62:4876-4878
4. Sixbey J: Epstein-Barr virus DNA loss from tumor cells and the geography of Burkitt's lymphoma. Epstein-Barr Virus Report 2000, 7:37-40
5. Gan YJ, Razzouk BI, Su T, Sixbey JW: A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease. Am J Pathol 2002, 160:781-786
6. Fan H, Gulley ML: Epstein-Barr viral load measurement as a marker of EBV-related disease. Mol Diagn 2001, 6:279-289
7. Glaser SL, Hsu JL, Gulley ML: Epstein-Barr virus and breast cancer: state of evidence for an association. Cancer Epidemiol Biomarkers Prevention 2004, 13:688-697
8. Chen PC, Pan CC, Yang AH, Wang LS, Chiang H: Detection of Epstein-Barr virus genome within thymic epithelial tumours in Taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization. J Pathol 2002, 197:684-688
9. Korabecna M, Ludvikova M, Skalova A: Molecular diagnosis of Epstein-Barr virus in paraffin-embedded tissues of tumors with abundant lymphoid infiltration. Neoplasma 2003, 50:8-12
10. Lauritzen AF, Hording U, Nielsen HW: Epstein-Barr virus and Hodgkin's disease: a comparative immunological, in situ hybridization, and polymerase chain reaction study. APMIS 1994, 102:495-500
11. Sanchez JL, Storch GA: Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J Clin Microbiol 2002, 40:2381-2386
12. Niedobitek G, Kremmer E, Herbst H, Whitehead L, Dawson CW, Niedobitek E, von Ostau C, Rooney N, Grassner FA, Young LS: Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis. Blood 1997, 90:1664-1672
13. Swinnen LJ, Gulley ML, Hamilton E, Schichman SA: EBV DNA quantitation in serum is highly correlated with the development and regression of post-transplant lymphoproliferative disorder (PTLD) in solid organ transplant recipients. Blood 1998, 92 (Suppl):314a
14. Chan KC, Lo YM: Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma. Semin Cancer Biol 2002, 12:489-496
15. Chan KC, Zhang J, Chan AT, Lei KI, Leung SF, Chan LY, Chow KC, Lo YM: Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res 2003, 63:2028-2032
16. Ryan JL, Fan H, Swinnen LJ, Schichman SA, Raab-Traub N, Covington M, Elmore S, Gulley ML: Epstein-Barr virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies. Diagn Mol Pathol 2004, 13:61-68